The United Kingdom Paediatric Critical Care Society Study Group: The 20-Year Journey Toward Pragmatic, Randomized Clinical Trials
- PMID: 36343185
- DOI: 10.1097/PCC.0000000000003099
The United Kingdom Paediatric Critical Care Society Study Group: The 20-Year Journey Toward Pragmatic, Randomized Clinical Trials
Abstract
Over the past two decades, pediatric intensive care research networks have been formed across North America, Europe, Asia, and Australia/New Zealand. The U.K. Paediatric Critical Care Society Study Group (PCCS-SG) has over a 20-year tradition of fostering collaborative research, leading to the design and successful conduct of randomized clinical trials (RCTs). To date, the PCCS-SG network has delivered 13 different multicenter RCTs, covering a spectrum of study designs, methodologies, and scale. Lessons from the early years have led PCCS-SG to now focus on the entire process needed for developing an RCT, starting from robust preparatory steps such as surveys, data analysis, and feasibility work through to a definitive RCT. Pilot RCTs have been an important part of this process as well. Facilitators of successful research have included the presence of a national registry to facilitate efficient data collection; close partnerships with established Clinical Trials Units to bring together clinicians, methodologists, statisticians, and trial managers; greater involvement of transport teams to recruit patients early in trials of time-sensitive interventions; and the funded infrastructure of clinical research staff within the National Health Service to integrate research within the clinical service. The informal nature of PCCS-SG has encouraged buy-in from clinicians. Greater international collaboration and development of embedded trial platforms to speed up the generation and dissemination of trial findings are two key future strategic goals for the PCCS-SG research network.
Copyright © 2022 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
Conflict of interest statement
Dr. Peters’ institution received funding from the National Institute of Health Research Health Technology Assessment grants; he received support for article research from the U.K. National Institute of Health and Social Care Research. Dr. Ramnarayan received funding from Sanofi. Dr. Tasker received funding from Society of Critical Care Medicine as the Editor-in-Chief of Pediatric Critical Care Medicine and from Oxford University Press, Up-to-Date, and Walters Kluwer. Dr. Scholefield is supported on a National Institute of Health and Social Care Research Clinician Scientist Fellowship. Dr. Tume has disclosed that he does not have any potential conflicts of interest.
References
-
- Macrae D, Grieve R, Allen E, et al.: A randomized trial of hyperglycemic control in pediatric intensive care. N Engl J Med 2014; 370:107–118
-
- Wolf A, McKay A, Spowart C, et al.: Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: The SLEEPS (safety profile, efficacy and equivalence in pediatric intensive care sedation) study. Health Technol Assess 2014; 18:1–212
-
- Gilbert RE, Mok Q, Dwan K, et al.: Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): A randomised controlled trial. Lancet 2016; 387:1732–1742
-
- Peters MJ, Agbeko R, Davis P, et al.: Randomized study of early continuous positive airways pressure in acute respiratory failure in children with impaired immunity (SCARF) ISRCTN82853500. Pediatr Crit Care Med 2018; 19:939–948
-
- Inwald D, Canter RR, Woolfall K, et al.: Restricted fluid bolus volume in early septic shock: results of the Fluids in Shock pilot trial. Arch Dis Child 2019; 104:426–431
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous